{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:06:04Z","timestamp":1780916764771,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760179, 81360151"],"award-info":[{"award-number":["81760179, 81360151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"crossref","award":["20171BAB205046"],"award-info":[{"award-number":["20171BAB205046"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Foundation of Education Department of Jiangxi Province","award":["GJJ160033"],"award-info":[{"award-number":["GJJ160033"]}]},{"name":"Health Development Planning Commission Science Foundation of Jiangxi Province","award":["20185118"],"award-info":[{"award-number":["20185118"]}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["20141BBG70027"],"award-info":[{"award-number":["20141BBG70027"]}],"id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12886-019-1200-4","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T09:03:03Z","timestamp":1566896583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab"],"prefix":"10.1186","volume":"19","author":[{"given":"Yuxiang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-6798","authenticated-orcid":false,"given":"Xiaorong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"issue":"22","key":"1200_CR1","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1001\/jama.2014.2536","volume":"311","author":"LM Jampol","year":"2014","unstructured":"Jampol LM, Bressler NM, Glassman AR. Revolution to a new standard treatment of diabetic macular edema. JAMA. 2014;311(22):2269\u201370.","journal-title":"JAMA"},{"issue":"13","key":"1200_CR2","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","volume":"372","author":"JA Wells","year":"2015","unstructured":"Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193\u2013203.","journal-title":"N Engl J Med"},{"issue":"6","key":"1200_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12325-017-0548-1","volume":"34","author":"N Dervenis","year":"2017","unstructured":"Dervenis N, Mikropoulou AM, Tranos P, Dervenis P. Ranibizumab in the treatment of diabetic macular edema: a review of the current status, unmet needs, and emerging challenges. Adv Ther. 2017;34(6):1270\u201382.","journal-title":"Adv Ther"},{"issue":"5","key":"1200_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ajo.2014.02.019","volume":"157","author":"O Comyn","year":"2014","unstructured":"Comyn O, Sivaprasad S, Peto T, Neveu MM, Holder GE, Xing W, Bunce CV, Patel PJ, Egan CA, Bainbridge JW, et al. A randomized trial to assess functional and structural effects of ranibizumab versus laser in diabetic macular edema (the LUCIDATE study). Am J Ophthalmol. 2014;157(5):960\u201370.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1200_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","volume":"119","author":"QD Nguyen","year":"2012","unstructured":"Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmol. 2012;119(4):789\u2013801.","journal-title":"Ophthalmol"},{"key":"1200_CR6","doi-asserted-by":"publisher","first-page":"582060","DOI":"10.1155\/2015\/582060","volume":"2015","author":"F Semeraro","year":"2015","unstructured":"Semeraro F, Cancarini A, Dell'Omo R, Rezzola S, Romano MR, Costagliola C. Diabetic retinopathy: vascular and inflammatory disease. J Diabetes Res. 2015;2015:582060.","journal-title":"J Diabetes Res"},{"issue":"2","key":"1200_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.eururo.2016.02.033","volume":"70","author":"AJ Templeton","year":"2016","unstructured":"Templeton AJ, Knox JJ, Lin X, Simantov R, Xie W, Lawrence N, Broom R, Fay AP, Rini B, Donskov F, et al. Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy. Eur Urol. 2016;70(2):358\u201364.","journal-title":"Eur Urol"},{"issue":"4","key":"1200_CR8","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1007\/s13277-015-4397-8","volume":"37","author":"Y Song","year":"2016","unstructured":"Song Y, Wang L, Hong Y, Lu Z, Tong Q, Fang X, Tan J. Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients. Tumor Biol. 2016;37(4):5285\u201393.","journal-title":"Tumor Biol"},{"issue":"5","key":"1200_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.7150\/jca.14206","volume":"7","author":"WK Eo","year":"2016","unstructured":"Eo WK, Kwon S, Koh SB, Kim MJ, Ji YI, Lee JY, Suh DS, Kim KH, Kim HY. The lymphocyte-monocyte ratio predicts patient survival and aggressiveness of endometrial Cancer. J Cancer. 2016;7(5):538\u201345.","journal-title":"J Cancer"},{"issue":"6","key":"1200_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.eururo.2014.02.042","volume":"66","author":"BR Viers","year":"2014","unstructured":"Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Eur Urol. 2014;66(6):1157\u201364.","journal-title":"Eur Urol"},{"key":"1200_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijcard.2016.08.260","volume":"223","author":"JF Condado","year":"2016","unstructured":"Condado JF, Junpaparp P, Binongo JN, Lasanajak Y, Witzke-Sanz CF, Devireddy C, Leshnower B, Mavromatis K, Stewart J, Guyton R, et al. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR). Int J Cardiol. 2016;223:444\u20139.","journal-title":"Int J Cardiol"},{"issue":"11","key":"1200_CR12","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00277-015-2462-4","volume":"94","author":"A Romano","year":"2015","unstructured":"Romano A, Parrinello NL, Consoli ML, Marchionni L, Forte S, Conticello C, Pompa A, Corso A, Milone G, Di Raimondo F, et al. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Ann Hematol. 2015;94(11):1875\u201383.","journal-title":"Ann Hematol"},{"issue":"11","key":"1200_CR13","first-page":"1716","volume":"10","author":"YX Hu","year":"2017","unstructured":"Hu YX, Xu XX, Shao Y, Yuan GL, Mei F, Zhou Q, Cheng Y, Wang J, Wu XR. The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity. Int J Ophthalmol. 2017;10(11):1716\u201321.","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"1200_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1055\/s-0035-1547257","volume":"123","author":"H Ciray","year":"2015","unstructured":"Ciray H, Aksoy AH, Ulu N, Cizmecioglu A, Gaipov A, Solak Y. Nephropathy, but not Angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2015;123(5):267\u201371.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"1200_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jdiacomp.2014.11.006","volume":"29","author":"RT Wang","year":"2015","unstructured":"Wang RT, Zhang JR, Li Y, Liu T, Yu KJ. Neutrophil-lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. J Diabetes Complicat. 2015;29(2):245\u20139.","journal-title":"J Diabetes Complicat"},{"issue":"8","key":"1200_CR16","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.3390\/ijerph120810009","volume":"12","author":"S Yue","year":"2015","unstructured":"Yue S, Zhang J, Wu J, Teng W, Liu L, Chen L. Use of the monocyte-to-lymphocyte ratio to predict diabetic retinopathy. Int J Env Res Pub He. 2015;12(8):10009\u201319.","journal-title":"Int J Env Res Pub He"},{"issue":"6","key":"1200_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.survophthal.2016.03.010","volume":"61","author":"DR Lally","year":"2016","unstructured":"Lally DR, Shah CP, Heier JS. Vascular endothelial growth factor and diabetic macular edema. Surv Ophthalmol. 2016;61(6):759\u201368.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1200_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","volume":"54","author":"N Bhagat","year":"2009","unstructured":"Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1\u201332.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"1200_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2012.08.017","volume":"58","author":"T Motomura","year":"2013","unstructured":"Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T, et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58(1):58\u201364.","journal-title":"J Hepatol"},{"key":"1200_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2017.01.013","volume":"106","author":"SJ Bagley","year":"2017","unstructured":"Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, et al. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer. 2017;106:1\u20137.","journal-title":"Lung Cancer"},{"issue":"7","key":"1200_CR21","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/bjc.2013.522","volume":"109","author":"M Santoni","year":"2013","unstructured":"Santoni M, De Giorgi U, Iacovelli R, Conti A, Burattini L, Rossi L, Luca BS, Berardi R, Muzzonigro G, Cortesi E, et al. Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. Br J Cancer. 2013;109(7):1755\u20139.","journal-title":"Br J Cancer"},{"key":"1200_CR22","first-page":"9327136","volume":"2017","author":"H Li","year":"2017","unstructured":"Li H, Lu X, Xiong R, Wang S. High neutrophil-to-lymphocyte ratio predicts cardiovascular mortality in chronic hemodialysis patients. Mediat Inflamm. 2017;2017:9327136.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"1200_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1161\/STROKEAHA.116.013627","volume":"47","author":"S Lattanzi","year":"2016","unstructured":"Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage. STROKE. 2016;47(6):1654\u20137.","journal-title":"STROKE"},{"issue":"11","key":"1200_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1089\/dia.2013.0097","volume":"15","author":"SM Ulu","year":"2013","unstructured":"Ulu SM, Dogan M, Ahsen A, Altug A, Demir K, Acarturk G, Inan S. Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. Diabetes Technol Ther. 2013;15(11):942\u20137.","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"1200_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1089\/dia.2013.0264","volume":"16","author":"A Shiny","year":"2014","unstructured":"Shiny A, Bibin YS, Shanthirani CS, Regin BS, Anjana RM, Balasubramanyam M, Jebarani S, Mohan V. Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes. Diabetes Technol Ther. 2014;16(8):524\u201330.","journal-title":"Diabetes Technol Ther"},{"key":"1200_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12902-015-0002-9","volume":"15","author":"M Lou","year":"2015","unstructured":"Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, He L. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"1200_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-017-0707-7","volume":"16","author":"A Ocana","year":"2017","unstructured":"Ocana A, Nieto-Jimenez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017;16(1):137.","journal-title":"Mol Cancer"},{"issue":"3","key":"1200_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1758834016638019","volume":"8","author":"S Chen","year":"2016","unstructured":"Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol. 2016;8(3):160\u20137.","journal-title":"Ther Adv Med Oncol"},{"issue":"10","key":"1200_CR29","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1038\/bjc.2014.163","volume":"110","author":"S Krenn-Pilko","year":"2014","unstructured":"Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110(10):2524\u201330.","journal-title":"Br J Cancer"},{"key":"1200_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1741-7015-11-184","volume":"11","author":"GM Warimwe","year":"2013","unstructured":"Warimwe GM, Fletcher HA, Olotu A, Agnandji ST, Hill AV, Marsh K, Bejon P. Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS, S malaria vaccine: analysis of pooled phase II clinical trial data. Bmc Med. 2013;11:184.","journal-title":"Bmc Med"},{"issue":"6","key":"1200_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.amjcard.2017.06.020","volume":"120","author":"CM Gijsberts","year":"2017","unstructured":"Gijsberts CM, Ellenbroek G, Ten BM, Huisman A, van Solinge WW, Lam CS, Asselbergs FW, den Ruijter HM, Pasterkamp G, Hoefer IE, et al. Effect of monocyte-to-lymphocyte ratio on heart failure characteristics and hospitalizations in a coronary angiography cohort. Am J Cardiol. 2017;120(6):911\u20136.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1200_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000443835","volume":"23","author":"G Serfozo","year":"2016","unstructured":"Serfozo G, Horvath T, Foldesi I, Rafael B, von Kanel R, Keresztes M. The monocyte-to-lymphocyte ratio correlates with psycho-neuro-inflammatory factors in patients with stable coronary artery disease. Neuroimmunomodulat. 2016;23(2):67\u201374.","journal-title":"Neuroimmunomodulat"},{"issue":"3","key":"1200_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2217\/bmm.14.100","volume":"9","author":"B Hudzik","year":"2015","unstructured":"Hudzik B, Szkodzinski J, Gorol J, Niedziela J, Lekston A, Gasior M, Polonski L. Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomark Med. 2015;9(3):199\u2013207.","journal-title":"Biomark Med"},{"issue":"4","key":"1200_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5414\/CN108584","volume":"85","author":"E Ahbap","year":"2016","unstructured":"Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T, Sevinc M, Akgol C, Kayalar AO, Ucar ZA, et al. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85(4):199\u2013208.","journal-title":"Clin Nephrol"},{"issue":"7","key":"1200_CR35","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ophtha.2015.02.036","volume":"122","author":"R Sophie","year":"2015","unstructured":"Sophie R, Lu N, Campochiaro PA. Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with Ranibizumab. Ophthalmology. 2015;122(7):1395\u2013401.","journal-title":"Ophthalmology"},{"issue":"16","key":"1200_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006459","volume":"96","author":"S Sato","year":"2017","unstructured":"Sato S, Shinoda H, Nagai N, Suzuki M, Uchida A, Kurihara T, Kamoshita M, Tomita Y, Iyama C, Minami S, et al. Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice. Medicine (Baltimore). 2017;96(16):e6459.","journal-title":"Medicine (Baltimore)"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1200-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1200-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T19:16:20Z","timestamp":1598382980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1200-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1200-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.9451\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9451\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.9451\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"27 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the First Affiliated Hospital of Nanchang University, and was performed in accordance with the principles of the Declaration of Helsinki. All of the subjects signed informed consent forms.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}